nodes	percent_of_prediction	percent_of_DWPC	metapath
Zonisamide—CA9—hematologic cancer	0.182	1	CbGaD
Zonisamide—CA3—Imatinib—hematologic cancer	0.0594	0.125	CbGbCtD
Zonisamide—CA3—Nilotinib—hematologic cancer	0.054	0.113	CbGbCtD
Zonisamide—AOX1—Mercaptopurine—hematologic cancer	0.025	0.0524	CbGbCtD
Zonisamide—CA14—Imatinib—hematologic cancer	0.0247	0.0518	CbGbCtD
Zonisamide—CA6—Imatinib—hematologic cancer	0.0234	0.0492	CbGbCtD
Zonisamide—CA14—Nilotinib—hematologic cancer	0.0224	0.0471	CbGbCtD
Zonisamide—CA6—Nilotinib—hematologic cancer	0.0213	0.0447	CbGbCtD
Zonisamide—CA7—Imatinib—hematologic cancer	0.0204	0.0429	CbGbCtD
Zonisamide—CA7—Nilotinib—hematologic cancer	0.0186	0.039	CbGbCtD
Zonisamide—CA9—Imatinib—hematologic cancer	0.0175	0.0368	CbGbCtD
Zonisamide—CA12—Imatinib—hematologic cancer	0.0175	0.0368	CbGbCtD
Zonisamide—CA1—Imatinib—hematologic cancer	0.0164	0.0344	CbGbCtD
Zonisamide—CA12—Nilotinib—hematologic cancer	0.0159	0.0334	CbGbCtD
Zonisamide—CA9—Nilotinib—hematologic cancer	0.0159	0.0334	CbGbCtD
Zonisamide—CA1—Nilotinib—hematologic cancer	0.0149	0.0313	CbGbCtD
Zonisamide—CA2—Imatinib—hematologic cancer	0.0142	0.0298	CbGbCtD
Zonisamide—CA4—Nilotinib—hematologic cancer	0.014	0.0294	CbGbCtD
Zonisamide—CA2—Nilotinib—hematologic cancer	0.0129	0.027	CbGbCtD
Zonisamide—AOX1—Methotrexate—hematologic cancer	0.00816	0.0171	CbGbCtD
Zonisamide—CYP2C19—Bortezomib—hematologic cancer	0.00411	0.00863	CbGbCtD
Zonisamide—CYP2C19—Thalidomide—hematologic cancer	0.00358	0.00752	CbGbCtD
Zonisamide—CYP2C19—Teniposide—hematologic cancer	0.00342	0.00717	CbGbCtD
Zonisamide—CYP3A4—Bexarotene—hematologic cancer	0.00324	0.00681	CbGbCtD
Zonisamide—CYP2C19—Ifosfamide—hematologic cancer	0.00315	0.00662	CbGbCtD
Zonisamide—CYP3A4—Busulfan—hematologic cancer	0.00301	0.00633	CbGbCtD
Zonisamide—CYP3A4—Lomustine—hematologic cancer	0.00301	0.00633	CbGbCtD
Zonisamide—CYP2C19—Imatinib—hematologic cancer	0.00301	0.00632	CbGbCtD
Zonisamide—CYP3A4—Thiotepa—hematologic cancer	0.00269	0.00564	CbGbCtD
Zonisamide—CYP3A4—Methoxsalen—hematologic cancer	0.00209	0.00439	CbGbCtD
Zonisamide—CYP3A4—Bortezomib—hematologic cancer	0.00199	0.00417	CbGbCtD
Zonisamide—CYP2C19—Prednisone—hematologic cancer	0.00198	0.00417	CbGbCtD
Zonisamide—CYP3A4—Daunorubicin—hematologic cancer	0.0019	0.00399	CbGbCtD
Zonisamide—CYP3A4—Cytarabine—hematologic cancer	0.00168	0.00352	CbGbCtD
Zonisamide—CYP3A4—Teniposide—hematologic cancer	0.00165	0.00347	CbGbCtD
Zonisamide—SCN1B—lung—hematologic cancer	0.00154	0.0313	CbGeAlD
Zonisamide—CYP3A4—Ifosfamide—hematologic cancer	0.00152	0.0032	CbGbCtD
Zonisamide—CYP3A4—Imatinib—hematologic cancer	0.00146	0.00306	CbGbCtD
Zonisamide—SCN1B—testis—hematologic cancer	0.00145	0.0296	CbGeAlD
Zonisamide—SCN3B—lung—hematologic cancer	0.00142	0.0289	CbGeAlD
Zonisamide—CA10—testis—hematologic cancer	0.00139	0.0283	CbGeAlD
Zonisamide—CYP3A4—Ruxolitinib—hematologic cancer	0.00137	0.00288	CbGbCtD
Zonisamide—CA8—testis—hematologic cancer	0.00137	0.0278	CbGeAlD
Zonisamide—SCN3B—testis—hematologic cancer	0.00134	0.0273	CbGeAlD
Zonisamide—CYP3A4—Nilotinib—hematologic cancer	0.00132	0.00278	CbGbCtD
Zonisamide—CYP3A4—Vinorelbine—hematologic cancer	0.00131	0.00275	CbGbCtD
Zonisamide—CYP2C19—Dexamethasone—hematologic cancer	0.00124	0.0026	CbGbCtD
Zonisamide—CA13—lung—hematologic cancer	0.00124	0.0252	CbGeAlD
Zonisamide—SCN4B—lung—hematologic cancer	0.00121	0.0246	CbGeAlD
Zonisamide—CYP3A4—Triamcinolone—hematologic cancer	0.0012	0.00252	CbGbCtD
Zonisamide—CA11—blood—hematologic cancer	0.00119	0.0241	CbGeAlD
Zonisamide—CYP3A4—Dasatinib—hematologic cancer	0.00117	0.00245	CbGbCtD
Zonisamide—CA13—testis—hematologic cancer	0.00117	0.0238	CbGeAlD
Zonisamide—CYP3A4—Mitoxantrone—hematologic cancer	0.00116	0.00242	CbGbCtD
Zonisamide—CA11—bone marrow—hematologic cancer	0.00115	0.0234	CbGeAlD
Zonisamide—SCN4B—testis—hematologic cancer	0.00114	0.0232	CbGeAlD
Zonisamide—CACNA1I—testis—hematologic cancer	0.00111	0.0227	CbGeAlD
Zonisamide—SCN1B—lymph node—hematologic cancer	0.00105	0.0214	CbGeAlD
Zonisamide—CA11—lung—hematologic cancer	0.00104	0.0212	CbGeAlD
Zonisamide—CYP3A4—Betamethasone—hematologic cancer	0.00103	0.00216	CbGbCtD
Zonisamide—CYP3A4—Prednisolone—hematologic cancer	0.00102	0.00213	CbGbCtD
Zonisamide—CA8—lymph node—hematologic cancer	0.00099	0.0201	CbGeAlD
Zonisamide—CA11—testis—hematologic cancer	0.000981	0.02	CbGeAlD
Zonisamide—SCN3B—lymph node—hematologic cancer	0.000971	0.0198	CbGeAlD
Zonisamide—CYP3A4—Prednisone—hematologic cancer	0.000959	0.00201	CbGbCtD
Zonisamide—CYP3A4—Irinotecan—hematologic cancer	0.000909	0.00191	CbGbCtD
Zonisamide—CA13—lymph node—hematologic cancer	0.000847	0.0172	CbGeAlD
Zonisamide—SCN4B—lymph node—hematologic cancer	0.000826	0.0168	CbGeAlD
Zonisamide—CYP3A4—Vinblastine—hematologic cancer	0.000809	0.0017	CbGbCtD
Zonisamide—CACNA1I—lymph node—hematologic cancer	0.000807	0.0164	CbGeAlD
Zonisamide—CYP3A4—Vincristine—hematologic cancer	0.000795	0.00167	CbGbCtD
Zonisamide—SCN2A—hematopoietic system—hematologic cancer	0.000767	0.0156	CbGeAlD
Zonisamide—CYP3A4—Etoposide—hematologic cancer	0.000728	0.00153	CbGbCtD
Zonisamide—CA11—lymph node—hematologic cancer	0.000711	0.0145	CbGeAlD
Zonisamide—CA3—bone marrow—hematologic cancer	0.0007	0.0143	CbGeAlD
Zonisamide—CA5B—hematopoietic system—hematologic cancer	0.000694	0.0141	CbGeAlD
Zonisamide—CACNA1H—gonad—hematologic cancer	0.000692	0.0141	CbGeAlD
Zonisamide—CA3—lung—hematologic cancer	0.000634	0.0129	CbGeAlD
Zonisamide—CA1—hematopoietic system—hematologic cancer	0.000613	0.0125	CbGeAlD
Zonisamide—CYP3A4—Dexamethasone—hematologic cancer	0.000599	0.00126	CbGbCtD
Zonisamide—CA3—testis—hematologic cancer	0.000599	0.0122	CbGeAlD
Zonisamide—CA9—testis—hematologic cancer	0.000573	0.0117	CbGeAlD
Zonisamide—SCN9A—lung—hematologic cancer	0.000564	0.0115	CbGeAlD
Zonisamide—SCN9A—testis—hematologic cancer	0.000533	0.0108	CbGeAlD
Zonisamide—CA5B—gonad—hematologic cancer	0.000528	0.0107	CbGeAlD
Zonisamide—SCN2A—blood—hematologic cancer	0.000508	0.0103	CbGeAlD
Zonisamide—CACNA1H—testis—hematologic cancer	0.000499	0.0102	CbGeAlD
Zonisamide—MAOB—hematopoietic system—hematologic cancer	0.000497	0.0101	CbGeAlD
Zonisamide—CYP3A4—Doxorubicin—hematologic cancer	0.000497	0.00104	CbGbCtD
Zonisamide—AOX1—gonad—hematologic cancer	0.000491	0.00999	CbGeAlD
Zonisamide—SCN1A—lung—hematologic cancer	0.000485	0.00988	CbGeAlD
Zonisamide—SCN4A—testis—hematologic cancer	0.000475	0.00967	CbGeAlD
Zonisamide—CA5B—blood—hematologic cancer	0.00046	0.00936	CbGeAlD
Zonisamide—CA12—lung—hematologic cancer	0.000449	0.00914	CbGeAlD
Zonisamide—SCN3A—blood—hematologic cancer	0.000447	0.00909	CbGeAlD
Zonisamide—SCN5A—blood—hematologic cancer	0.000445	0.00907	CbGeAlD
Zonisamide—CA3—lymph node—hematologic cancer	0.000434	0.00883	CbGeAlD
Zonisamide—CYP2C19—hematopoietic system—hematologic cancer	0.000433	0.00882	CbGeAlD
Zonisamide—SCN3A—bone marrow—hematologic cancer	0.000432	0.0088	CbGeAlD
Zonisamide—MAOA—hematopoietic system—hematologic cancer	0.000424	0.00863	CbGeAlD
Zonisamide—CA1—blood—hematologic cancer	0.000406	0.00826	CbGeAlD
Zonisamide—CA5B—lung—hematologic cancer	0.000403	0.0082	CbGeAlD
Zonisamide—CA2—hematopoietic system—hematologic cancer	0.000397	0.00808	CbGeAlD
Zonisamide—CA1—bone marrow—hematologic cancer	0.000393	0.00799	CbGeAlD
Zonisamide—SCN3A—lung—hematologic cancer	0.000392	0.00797	CbGeAlD
Zonisamide—SCN9A—lymph node—hematologic cancer	0.000386	0.00786	CbGeAlD
Zonisamide—CA5B—testis—hematologic cancer	0.00038	0.00774	CbGeAlD
Zonisamide—AOX1—lung—hematologic cancer	0.000375	0.00763	CbGeAlD
Zonisamide—SCN3A—testis—hematologic cancer	0.00037	0.00752	CbGeAlD
Zonisamide—CACNA1H—lymph node—hematologic cancer	0.000362	0.00736	CbGeAlD
Zonisamide—CA1—lung—hematologic cancer	0.000356	0.00724	CbGeAlD
Zonisamide—AOX1—testis—hematologic cancer	0.000354	0.0072	CbGeAlD
Zonisamide—MAOB—blood—hematologic cancer	0.000329	0.0067	CbGeAlD
Zonisamide—CA4—blood—hematologic cancer	0.000317	0.00646	CbGeAlD
Zonisamide—CA4—bone marrow—hematologic cancer	0.000307	0.00625	CbGeAlD
Zonisamide—MAOB—lung—hematologic cancer	0.000289	0.00588	CbGeAlD
Zonisamide—CYP2C19—blood—hematologic cancer	0.000287	0.00584	CbGeAlD
Zonisamide—MAOA—blood—hematologic cancer	0.000281	0.00572	CbGeAlD
Zonisamide—CA4—lung—hematologic cancer	0.000278	0.00566	CbGeAlD
Zonisamide—CA5B—lymph node—hematologic cancer	0.000276	0.00561	CbGeAlD
Zonisamide—MAOB—testis—hematologic cancer	0.000272	0.00555	CbGeAlD
Zonisamide—SCN3A—lymph node—hematologic cancer	0.000268	0.00545	CbGeAlD
Zonisamide—CA2—blood—hematologic cancer	0.000263	0.00535	CbGeAlD
Zonisamide—CA4—testis—hematologic cancer	0.000262	0.00534	CbGeAlD
Zonisamide—AOX1—lymph node—hematologic cancer	0.000256	0.00522	CbGeAlD
Zonisamide—CYP3A4—hematopoietic system—hematologic cancer	0.000256	0.00521	CbGeAlD
Zonisamide—CA2—bone marrow—hematologic cancer	0.000255	0.00518	CbGeAlD
Zonisamide—MAOA—lung—hematologic cancer	0.000246	0.00501	CbGeAlD
Zonisamide—CA1—lymph node—hematologic cancer	0.000243	0.00495	CbGeAlD
Zonisamide—MAOA—testis—hematologic cancer	0.000232	0.00473	CbGeAlD
Zonisamide—CA2—lung—hematologic cancer	0.000231	0.00469	CbGeAlD
Zonisamide—CA2—testis—hematologic cancer	0.000218	0.00443	CbGeAlD
Zonisamide—MAOB—lymph node—hematologic cancer	0.000198	0.00402	CbGeAlD
Zonisamide—CA4—lymph node—hematologic cancer	0.00019	0.00387	CbGeAlD
Zonisamide—CYP3A4—blood—hematologic cancer	0.00017	0.00345	CbGeAlD
Zonisamide—MAOA—lymph node—hematologic cancer	0.000169	0.00343	CbGeAlD
Zonisamide—CA2—lymph node—hematologic cancer	0.000158	0.00321	CbGeAlD
Zonisamide—Hyperhidrosis—Prednisone—hematologic cancer	1.24e-05	6.57e-05	CcSEcCtD
Zonisamide—Mental disorder—Epirubicin—hematologic cancer	1.23e-05	6.56e-05	CcSEcCtD
Zonisamide—Erythema multiforme—Doxorubicin—hematologic cancer	1.23e-05	6.55e-05	CcSEcCtD
Zonisamide—Rash—Cisplatin—hematologic cancer	1.23e-05	6.53e-05	CcSEcCtD
Zonisamide—Dermatitis—Cisplatin—hematologic cancer	1.23e-05	6.52e-05	CcSEcCtD
Zonisamide—Malnutrition—Epirubicin—hematologic cancer	1.23e-05	6.51e-05	CcSEcCtD
Zonisamide—Diarrhoea—Etoposide—hematologic cancer	1.22e-05	6.49e-05	CcSEcCtD
Zonisamide—Anorexia—Prednisone—hematologic cancer	1.22e-05	6.48e-05	CcSEcCtD
Zonisamide—Eye disorder—Doxorubicin—hematologic cancer	1.22e-05	6.47e-05	CcSEcCtD
Zonisamide—Ill-defined disorder—Methotrexate—hematologic cancer	1.22e-05	6.46e-05	CcSEcCtD
Zonisamide—Tinnitus—Doxorubicin—hematologic cancer	1.22e-05	6.46e-05	CcSEcCtD
Zonisamide—Anaemia—Methotrexate—hematologic cancer	1.21e-05	6.43e-05	CcSEcCtD
Zonisamide—Feeling abnormal—Dexamethasone—hematologic cancer	1.21e-05	6.43e-05	CcSEcCtD
Zonisamide—Feeling abnormal—Betamethasone—hematologic cancer	1.21e-05	6.43e-05	CcSEcCtD
Zonisamide—Flatulence—Epirubicin—hematologic cancer	1.21e-05	6.42e-05	CcSEcCtD
Zonisamide—Tension—Epirubicin—hematologic cancer	1.2e-05	6.39e-05	CcSEcCtD
Zonisamide—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.2e-05	6.38e-05	CcSEcCtD
Zonisamide—Gastrointestinal pain—Betamethasone—hematologic cancer	1.2e-05	6.38e-05	CcSEcCtD
Zonisamide—Dysgeusia—Epirubicin—hematologic cancer	1.2e-05	6.38e-05	CcSEcCtD
Zonisamide—Hypersensitivity—Triamcinolone—hematologic cancer	1.19e-05	6.34e-05	CcSEcCtD
Zonisamide—Nervousness—Epirubicin—hematologic cancer	1.19e-05	6.33e-05	CcSEcCtD
Zonisamide—Malaise—Methotrexate—hematologic cancer	1.18e-05	6.28e-05	CcSEcCtD
Zonisamide—Dizziness—Etoposide—hematologic cancer	1.18e-05	6.27e-05	CcSEcCtD
Zonisamide—Muscle spasms—Epirubicin—hematologic cancer	1.18e-05	6.26e-05	CcSEcCtD
Zonisamide—Immune system disorder—Doxorubicin—hematologic cancer	1.18e-05	6.25e-05	CcSEcCtD
Zonisamide—Vertigo—Methotrexate—hematologic cancer	1.18e-05	6.25e-05	CcSEcCtD
Zonisamide—Mediastinal disorder—Doxorubicin—hematologic cancer	1.18e-05	6.24e-05	CcSEcCtD
Zonisamide—Leukopenia—Methotrexate—hematologic cancer	1.17e-05	6.23e-05	CcSEcCtD
Zonisamide—Urticaria—Dexamethasone—hematologic cancer	1.17e-05	6.2e-05	CcSEcCtD
Zonisamide—Urticaria—Betamethasone—hematologic cancer	1.17e-05	6.2e-05	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.17e-05	6.19e-05	CcSEcCtD
Zonisamide—Dizziness—Prednisolone—hematologic cancer	1.16e-05	6.19e-05	CcSEcCtD
Zonisamide—Asthenia—Triamcinolone—hematologic cancer	1.16e-05	6.17e-05	CcSEcCtD
Zonisamide—Abdominal pain—Dexamethasone—hematologic cancer	1.16e-05	6.17e-05	CcSEcCtD
Zonisamide—Body temperature increased—Dexamethasone—hematologic cancer	1.16e-05	6.17e-05	CcSEcCtD
Zonisamide—Abdominal pain—Betamethasone—hematologic cancer	1.16e-05	6.17e-05	CcSEcCtD
Zonisamide—Body temperature increased—Betamethasone—hematologic cancer	1.16e-05	6.17e-05	CcSEcCtD
Zonisamide—Nausea—Cisplatin—hematologic cancer	1.16e-05	6.15e-05	CcSEcCtD
Zonisamide—Insomnia—Prednisone—hematologic cancer	1.16e-05	6.15e-05	CcSEcCtD
Zonisamide—Alopecia—Doxorubicin—hematologic cancer	1.15e-05	6.12e-05	CcSEcCtD
Zonisamide—Paraesthesia—Prednisone—hematologic cancer	1.15e-05	6.1e-05	CcSEcCtD
Zonisamide—Pruritus—Triamcinolone—hematologic cancer	1.15e-05	6.09e-05	CcSEcCtD
Zonisamide—Cough—Methotrexate—hematologic cancer	1.14e-05	6.07e-05	CcSEcCtD
Zonisamide—Mental disorder—Doxorubicin—hematologic cancer	1.14e-05	6.07e-05	CcSEcCtD
Zonisamide—Ill-defined disorder—Epirubicin—hematologic cancer	1.14e-05	6.04e-05	CcSEcCtD
Zonisamide—Convulsion—Methotrexate—hematologic cancer	1.14e-05	6.03e-05	CcSEcCtD
Zonisamide—Vomiting—Etoposide—hematologic cancer	1.14e-05	6.03e-05	CcSEcCtD
Zonisamide—Malnutrition—Doxorubicin—hematologic cancer	1.14e-05	6.03e-05	CcSEcCtD
Zonisamide—Anaemia—Epirubicin—hematologic cancer	1.13e-05	6.02e-05	CcSEcCtD
Zonisamide—Agitation—Epirubicin—hematologic cancer	1.13e-05	5.99e-05	CcSEcCtD
Zonisamide—Dyspepsia—Prednisone—hematologic cancer	1.13e-05	5.98e-05	CcSEcCtD
Zonisamide—Rash—Etoposide—hematologic cancer	1.13e-05	5.98e-05	CcSEcCtD
Zonisamide—Dermatitis—Etoposide—hematologic cancer	1.13e-05	5.97e-05	CcSEcCtD
Zonisamide—Headache—Etoposide—hematologic cancer	1.12e-05	5.94e-05	CcSEcCtD
Zonisamide—Flatulence—Doxorubicin—hematologic cancer	1.12e-05	5.94e-05	CcSEcCtD
Zonisamide—Chest pain—Methotrexate—hematologic cancer	1.12e-05	5.93e-05	CcSEcCtD
Zonisamide—Myalgia—Methotrexate—hematologic cancer	1.12e-05	5.93e-05	CcSEcCtD
Zonisamide—Arthralgia—Methotrexate—hematologic cancer	1.12e-05	5.93e-05	CcSEcCtD
Zonisamide—Tension—Doxorubicin—hematologic cancer	1.11e-05	5.91e-05	CcSEcCtD
Zonisamide—Decreased appetite—Prednisone—hematologic cancer	1.11e-05	5.91e-05	CcSEcCtD
Zonisamide—Dysgeusia—Doxorubicin—hematologic cancer	1.11e-05	5.9e-05	CcSEcCtD
Zonisamide—Rash—Prednisolone—hematologic cancer	1.11e-05	5.9e-05	CcSEcCtD
Zonisamide—Dermatitis—Prednisolone—hematologic cancer	1.11e-05	5.89e-05	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.11e-05	5.88e-05	CcSEcCtD
Zonisamide—Malaise—Epirubicin—hematologic cancer	1.11e-05	5.87e-05	CcSEcCtD
Zonisamide—Fatigue—Prednisone—hematologic cancer	1.1e-05	5.86e-05	CcSEcCtD
Zonisamide—Headache—Prednisolone—hematologic cancer	1.1e-05	5.86e-05	CcSEcCtD
Zonisamide—Discomfort—Methotrexate—hematologic cancer	1.1e-05	5.85e-05	CcSEcCtD
Zonisamide—Nervousness—Doxorubicin—hematologic cancer	1.1e-05	5.85e-05	CcSEcCtD
Zonisamide—Vertigo—Epirubicin—hematologic cancer	1.1e-05	5.85e-05	CcSEcCtD
Zonisamide—Syncope—Epirubicin—hematologic cancer	1.1e-05	5.84e-05	CcSEcCtD
Zonisamide—Leukopenia—Epirubicin—hematologic cancer	1.1e-05	5.83e-05	CcSEcCtD
Zonisamide—Constipation—Prednisone—hematologic cancer	1.09e-05	5.81e-05	CcSEcCtD
Zonisamide—Muscle spasms—Doxorubicin—hematologic cancer	1.09e-05	5.79e-05	CcSEcCtD
Zonisamide—Palpitations—Epirubicin—hematologic cancer	1.08e-05	5.76e-05	CcSEcCtD
Zonisamide—Confusional state—Methotrexate—hematologic cancer	1.08e-05	5.73e-05	CcSEcCtD
Zonisamide—Loss of consciousness—Epirubicin—hematologic cancer	1.08e-05	5.73e-05	CcSEcCtD
Zonisamide—Dizziness—Triamcinolone—hematologic cancer	1.07e-05	5.69e-05	CcSEcCtD
Zonisamide—Cough—Epirubicin—hematologic cancer	1.07e-05	5.68e-05	CcSEcCtD
Zonisamide—Convulsion—Epirubicin—hematologic cancer	1.06e-05	5.64e-05	CcSEcCtD
Zonisamide—Infection—Methotrexate—hematologic cancer	1.06e-05	5.64e-05	CcSEcCtD
Zonisamide—Nausea—Etoposide—hematologic cancer	1.06e-05	5.63e-05	CcSEcCtD
Zonisamide—Hypertension—Epirubicin—hematologic cancer	1.06e-05	5.62e-05	CcSEcCtD
Zonisamide—Feeling abnormal—Prednisone—hematologic cancer	1.05e-05	5.6e-05	CcSEcCtD
Zonisamide—Asthenia—Dexamethasone—hematologic cancer	1.05e-05	5.6e-05	CcSEcCtD
Zonisamide—Asthenia—Betamethasone—hematologic cancer	1.05e-05	5.6e-05	CcSEcCtD
Zonisamide—Ill-defined disorder—Doxorubicin—hematologic cancer	1.05e-05	5.59e-05	CcSEcCtD
Zonisamide—Nervous system disorder—Methotrexate—hematologic cancer	1.05e-05	5.57e-05	CcSEcCtD
Zonisamide—Anaemia—Doxorubicin—hematologic cancer	1.05e-05	5.57e-05	CcSEcCtD
Zonisamide—Thrombocytopenia—Methotrexate—hematologic cancer	1.05e-05	5.56e-05	CcSEcCtD
Zonisamide—Gastrointestinal pain—Prednisone—hematologic cancer	1.05e-05	5.56e-05	CcSEcCtD
Zonisamide—Nausea—Prednisolone—hematologic cancer	1.05e-05	5.56e-05	CcSEcCtD
Zonisamide—Myalgia—Epirubicin—hematologic cancer	1.04e-05	5.55e-05	CcSEcCtD
Zonisamide—Chest pain—Epirubicin—hematologic cancer	1.04e-05	5.55e-05	CcSEcCtD
Zonisamide—Arthralgia—Epirubicin—hematologic cancer	1.04e-05	5.55e-05	CcSEcCtD
Zonisamide—Agitation—Doxorubicin—hematologic cancer	1.04e-05	5.54e-05	CcSEcCtD
Zonisamide—Anxiety—Epirubicin—hematologic cancer	1.04e-05	5.53e-05	CcSEcCtD
Zonisamide—Pruritus—Dexamethasone—hematologic cancer	1.04e-05	5.52e-05	CcSEcCtD
Zonisamide—Pruritus—Betamethasone—hematologic cancer	1.04e-05	5.52e-05	CcSEcCtD
Zonisamide—Skin disorder—Methotrexate—hematologic cancer	1.04e-05	5.52e-05	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.04e-05	5.51e-05	CcSEcCtD
Zonisamide—Hyperhidrosis—Methotrexate—hematologic cancer	1.03e-05	5.49e-05	CcSEcCtD
Zonisamide—Discomfort—Epirubicin—hematologic cancer	1.03e-05	5.48e-05	CcSEcCtD
Zonisamide—Vomiting—Triamcinolone—hematologic cancer	1.03e-05	5.47e-05	CcSEcCtD
Zonisamide—Malaise—Doxorubicin—hematologic cancer	1.02e-05	5.44e-05	CcSEcCtD
Zonisamide—Rash—Triamcinolone—hematologic cancer	1.02e-05	5.42e-05	CcSEcCtD
Zonisamide—Dry mouth—Epirubicin—hematologic cancer	1.02e-05	5.42e-05	CcSEcCtD
Zonisamide—Dermatitis—Triamcinolone—hematologic cancer	1.02e-05	5.42e-05	CcSEcCtD
Zonisamide—Vertigo—Doxorubicin—hematologic cancer	1.02e-05	5.41e-05	CcSEcCtD
Zonisamide—Anorexia—Methotrexate—hematologic cancer	1.02e-05	5.41e-05	CcSEcCtD
Zonisamide—Syncope—Doxorubicin—hematologic cancer	1.02e-05	5.4e-05	CcSEcCtD
Zonisamide—Urticaria—Prednisone—hematologic cancer	1.02e-05	5.4e-05	CcSEcCtD
Zonisamide—Leukopenia—Doxorubicin—hematologic cancer	1.02e-05	5.39e-05	CcSEcCtD
Zonisamide—Headache—Triamcinolone—hematologic cancer	1.01e-05	5.39e-05	CcSEcCtD
Zonisamide—Abdominal pain—Prednisone—hematologic cancer	1.01e-05	5.37e-05	CcSEcCtD
Zonisamide—Body temperature increased—Prednisone—hematologic cancer	1.01e-05	5.37e-05	CcSEcCtD
Zonisamide—Confusional state—Epirubicin—hematologic cancer	1.01e-05	5.36e-05	CcSEcCtD
Zonisamide—Diarrhoea—Betamethasone—hematologic cancer	1.01e-05	5.34e-05	CcSEcCtD
Zonisamide—Diarrhoea—Dexamethasone—hematologic cancer	1.01e-05	5.34e-05	CcSEcCtD
Zonisamide—Palpitations—Doxorubicin—hematologic cancer	1e-05	5.33e-05	CcSEcCtD
Zonisamide—Oedema—Epirubicin—hematologic cancer	1e-05	5.32e-05	CcSEcCtD
Zonisamide—Hypotension—Methotrexate—hematologic cancer	1e-05	5.31e-05	CcSEcCtD
Zonisamide—Loss of consciousness—Doxorubicin—hematologic cancer	9.98e-06	5.3e-05	CcSEcCtD
Zonisamide—Infection—Epirubicin—hematologic cancer	9.95e-06	5.28e-05	CcSEcCtD
Zonisamide—Cough—Doxorubicin—hematologic cancer	9.91e-06	5.26e-05	CcSEcCtD
Zonisamide—Shock—Epirubicin—hematologic cancer	9.85e-06	5.23e-05	CcSEcCtD
Zonisamide—Convulsion—Doxorubicin—hematologic cancer	9.83e-06	5.22e-05	CcSEcCtD
Zonisamide—Nervous system disorder—Epirubicin—hematologic cancer	9.82e-06	5.21e-05	CcSEcCtD
Zonisamide—Thrombocytopenia—Epirubicin—hematologic cancer	9.8e-06	5.21e-05	CcSEcCtD
Zonisamide—Hypertension—Doxorubicin—hematologic cancer	9.8e-06	5.2e-05	CcSEcCtD
Zonisamide—Tachycardia—Epirubicin—hematologic cancer	9.77e-06	5.19e-05	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Methotrexate—hematologic cancer	9.75e-06	5.18e-05	CcSEcCtD
Zonisamide—Skin disorder—Epirubicin—hematologic cancer	9.73e-06	5.16e-05	CcSEcCtD
Zonisamide—Dizziness—Dexamethasone—hematologic cancer	9.72e-06	5.16e-05	CcSEcCtD
Zonisamide—Dizziness—Betamethasone—hematologic cancer	9.72e-06	5.16e-05	CcSEcCtD
Zonisamide—Hyperhidrosis—Epirubicin—hematologic cancer	9.68e-06	5.14e-05	CcSEcCtD
Zonisamide—Insomnia—Methotrexate—hematologic cancer	9.68e-06	5.14e-05	CcSEcCtD
Zonisamide—Arthralgia—Doxorubicin—hematologic cancer	9.66e-06	5.13e-05	CcSEcCtD
Zonisamide—Myalgia—Doxorubicin—hematologic cancer	9.66e-06	5.13e-05	CcSEcCtD
Zonisamide—Chest pain—Doxorubicin—hematologic cancer	9.66e-06	5.13e-05	CcSEcCtD
Zonisamide—Anxiety—Doxorubicin—hematologic cancer	9.63e-06	5.11e-05	CcSEcCtD
Zonisamide—Nausea—Triamcinolone—hematologic cancer	9.62e-06	5.11e-05	CcSEcCtD
Zonisamide—Paraesthesia—Methotrexate—hematologic cancer	9.61e-06	5.1e-05	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	9.6e-06	5.1e-05	CcSEcCtD
Zonisamide—Discomfort—Doxorubicin—hematologic cancer	9.55e-06	5.07e-05	CcSEcCtD
Zonisamide—Anorexia—Epirubicin—hematologic cancer	9.54e-06	5.07e-05	CcSEcCtD
Zonisamide—Dyspnoea—Methotrexate—hematologic cancer	9.54e-06	5.06e-05	CcSEcCtD
Zonisamide—Somnolence—Methotrexate—hematologic cancer	9.51e-06	5.05e-05	CcSEcCtD
Zonisamide—Dry mouth—Doxorubicin—hematologic cancer	9.45e-06	5.02e-05	CcSEcCtD
Zonisamide—Hypersensitivity—Prednisone—hematologic cancer	9.43e-06	5.01e-05	CcSEcCtD
Zonisamide—Dyspepsia—Methotrexate—hematologic cancer	9.42e-06	5e-05	CcSEcCtD
Zonisamide—Hypotension—Epirubicin—hematologic cancer	9.36e-06	4.97e-05	CcSEcCtD
Zonisamide—Vomiting—Dexamethasone—hematologic cancer	9.35e-06	4.96e-05	CcSEcCtD
Zonisamide—Vomiting—Betamethasone—hematologic cancer	9.35e-06	4.96e-05	CcSEcCtD
Zonisamide—Confusional state—Doxorubicin—hematologic cancer	9.34e-06	4.96e-05	CcSEcCtD
Zonisamide—Decreased appetite—Methotrexate—hematologic cancer	9.3e-06	4.94e-05	CcSEcCtD
Zonisamide—Rash—Betamethasone—hematologic cancer	9.27e-06	4.92e-05	CcSEcCtD
Zonisamide—Rash—Dexamethasone—hematologic cancer	9.27e-06	4.92e-05	CcSEcCtD
Zonisamide—Oedema—Doxorubicin—hematologic cancer	9.26e-06	4.92e-05	CcSEcCtD
Zonisamide—Dermatitis—Dexamethasone—hematologic cancer	9.26e-06	4.92e-05	CcSEcCtD
Zonisamide—Dermatitis—Betamethasone—hematologic cancer	9.26e-06	4.92e-05	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Methotrexate—hematologic cancer	9.24e-06	4.9e-05	CcSEcCtD
Zonisamide—Fatigue—Methotrexate—hematologic cancer	9.22e-06	4.9e-05	CcSEcCtD
Zonisamide—Headache—Dexamethasone—hematologic cancer	9.21e-06	4.89e-05	CcSEcCtD
Zonisamide—Headache—Betamethasone—hematologic cancer	9.21e-06	4.89e-05	CcSEcCtD
Zonisamide—Infection—Doxorubicin—hematologic cancer	9.2e-06	4.89e-05	CcSEcCtD
Zonisamide—Asthenia—Prednisone—hematologic cancer	9.18e-06	4.88e-05	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Epirubicin—hematologic cancer	9.12e-06	4.84e-05	CcSEcCtD
Zonisamide—Shock—Doxorubicin—hematologic cancer	9.11e-06	4.84e-05	CcSEcCtD
Zonisamide—Nervous system disorder—Doxorubicin—hematologic cancer	9.09e-06	4.82e-05	CcSEcCtD
Zonisamide—Thrombocytopenia—Doxorubicin—hematologic cancer	9.07e-06	4.82e-05	CcSEcCtD
Zonisamide—Pruritus—Prednisone—hematologic cancer	9.06e-06	4.81e-05	CcSEcCtD
Zonisamide—Insomnia—Epirubicin—hematologic cancer	9.06e-06	4.81e-05	CcSEcCtD
Zonisamide—Tachycardia—Doxorubicin—hematologic cancer	9.04e-06	4.8e-05	CcSEcCtD
Zonisamide—Skin disorder—Doxorubicin—hematologic cancer	9e-06	4.78e-05	CcSEcCtD
Zonisamide—Paraesthesia—Epirubicin—hematologic cancer	8.99e-06	4.77e-05	CcSEcCtD
Zonisamide—Hyperhidrosis—Doxorubicin—hematologic cancer	8.96e-06	4.76e-05	CcSEcCtD
Zonisamide—Dyspnoea—Epirubicin—hematologic cancer	8.93e-06	4.74e-05	CcSEcCtD
Zonisamide—Somnolence—Epirubicin—hematologic cancer	8.9e-06	4.73e-05	CcSEcCtD
Zonisamide—Anorexia—Doxorubicin—hematologic cancer	8.83e-06	4.69e-05	CcSEcCtD
Zonisamide—Feeling abnormal—Methotrexate—hematologic cancer	8.82e-06	4.68e-05	CcSEcCtD
Zonisamide—Dyspepsia—Epirubicin—hematologic cancer	8.81e-06	4.68e-05	CcSEcCtD
Zonisamide—Diarrhoea—Prednisone—hematologic cancer	8.76e-06	4.65e-05	CcSEcCtD
Zonisamide—Gastrointestinal pain—Methotrexate—hematologic cancer	8.75e-06	4.65e-05	CcSEcCtD
Zonisamide—Nausea—Dexamethasone—hematologic cancer	8.73e-06	4.64e-05	CcSEcCtD
Zonisamide—Nausea—Betamethasone—hematologic cancer	8.73e-06	4.64e-05	CcSEcCtD
Zonisamide—Decreased appetite—Epirubicin—hematologic cancer	8.7e-06	4.62e-05	CcSEcCtD
Zonisamide—Hypotension—Doxorubicin—hematologic cancer	8.66e-06	4.6e-05	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Epirubicin—hematologic cancer	8.64e-06	4.59e-05	CcSEcCtD
Zonisamide—Fatigue—Epirubicin—hematologic cancer	8.63e-06	4.58e-05	CcSEcCtD
Zonisamide—Constipation—Epirubicin—hematologic cancer	8.56e-06	4.55e-05	CcSEcCtD
Zonisamide—Urticaria—Methotrexate—hematologic cancer	8.5e-06	4.51e-05	CcSEcCtD
Zonisamide—Dizziness—Prednisone—hematologic cancer	8.47e-06	4.49e-05	CcSEcCtD
Zonisamide—Body temperature increased—Methotrexate—hematologic cancer	8.46e-06	4.49e-05	CcSEcCtD
Zonisamide—Abdominal pain—Methotrexate—hematologic cancer	8.46e-06	4.49e-05	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	8.44e-06	4.48e-05	CcSEcCtD
Zonisamide—Insomnia—Doxorubicin—hematologic cancer	8.38e-06	4.45e-05	CcSEcCtD
Zonisamide—Paraesthesia—Doxorubicin—hematologic cancer	8.32e-06	4.42e-05	CcSEcCtD
Zonisamide—Dyspnoea—Doxorubicin—hematologic cancer	8.26e-06	4.39e-05	CcSEcCtD
Zonisamide—Feeling abnormal—Epirubicin—hematologic cancer	8.25e-06	4.38e-05	CcSEcCtD
Zonisamide—Somnolence—Doxorubicin—hematologic cancer	8.24e-06	4.37e-05	CcSEcCtD
Zonisamide—Gastrointestinal pain—Epirubicin—hematologic cancer	8.19e-06	4.35e-05	CcSEcCtD
Zonisamide—Dyspepsia—Doxorubicin—hematologic cancer	8.15e-06	4.33e-05	CcSEcCtD
Zonisamide—Vomiting—Prednisone—hematologic cancer	8.14e-06	4.32e-05	CcSEcCtD
Zonisamide—Rash—Prednisone—hematologic cancer	8.07e-06	4.29e-05	CcSEcCtD
Zonisamide—Dermatitis—Prednisone—hematologic cancer	8.06e-06	4.28e-05	CcSEcCtD
Zonisamide—Decreased appetite—Doxorubicin—hematologic cancer	8.05e-06	4.28e-05	CcSEcCtD
Zonisamide—Headache—Prednisone—hematologic cancer	8.02e-06	4.26e-05	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Doxorubicin—hematologic cancer	8e-06	4.25e-05	CcSEcCtD
Zonisamide—Fatigue—Doxorubicin—hematologic cancer	7.99e-06	4.24e-05	CcSEcCtD
Zonisamide—Urticaria—Epirubicin—hematologic cancer	7.95e-06	4.22e-05	CcSEcCtD
Zonisamide—Constipation—Doxorubicin—hematologic cancer	7.92e-06	4.21e-05	CcSEcCtD
Zonisamide—Body temperature increased—Epirubicin—hematologic cancer	7.91e-06	4.2e-05	CcSEcCtD
Zonisamide—Abdominal pain—Epirubicin—hematologic cancer	7.91e-06	4.2e-05	CcSEcCtD
Zonisamide—Hypersensitivity—Methotrexate—hematologic cancer	7.88e-06	4.19e-05	CcSEcCtD
Zonisamide—Asthenia—Methotrexate—hematologic cancer	7.68e-06	4.08e-05	CcSEcCtD
Zonisamide—Feeling abnormal—Doxorubicin—hematologic cancer	7.63e-06	4.05e-05	CcSEcCtD
Zonisamide—Nausea—Prednisone—hematologic cancer	7.6e-06	4.04e-05	CcSEcCtD
Zonisamide—Gastrointestinal pain—Doxorubicin—hematologic cancer	7.58e-06	4.02e-05	CcSEcCtD
Zonisamide—Pruritus—Methotrexate—hematologic cancer	7.57e-06	4.02e-05	CcSEcCtD
Zonisamide—Hypersensitivity—Epirubicin—hematologic cancer	7.38e-06	3.92e-05	CcSEcCtD
Zonisamide—Urticaria—Doxorubicin—hematologic cancer	7.36e-06	3.91e-05	CcSEcCtD
Zonisamide—Body temperature increased—Doxorubicin—hematologic cancer	7.32e-06	3.89e-05	CcSEcCtD
Zonisamide—Abdominal pain—Doxorubicin—hematologic cancer	7.32e-06	3.89e-05	CcSEcCtD
Zonisamide—Diarrhoea—Methotrexate—hematologic cancer	7.32e-06	3.89e-05	CcSEcCtD
Zonisamide—Asthenia—Epirubicin—hematologic cancer	7.18e-06	3.81e-05	CcSEcCtD
Zonisamide—Pruritus—Epirubicin—hematologic cancer	7.08e-06	3.76e-05	CcSEcCtD
Zonisamide—Dizziness—Methotrexate—hematologic cancer	7.07e-06	3.76e-05	CcSEcCtD
Zonisamide—Diarrhoea—Epirubicin—hematologic cancer	6.85e-06	3.64e-05	CcSEcCtD
Zonisamide—Hypersensitivity—Doxorubicin—hematologic cancer	6.83e-06	3.62e-05	CcSEcCtD
Zonisamide—Vomiting—Methotrexate—hematologic cancer	6.8e-06	3.61e-05	CcSEcCtD
Zonisamide—Rash—Methotrexate—hematologic cancer	6.75e-06	3.58e-05	CcSEcCtD
Zonisamide—Dermatitis—Methotrexate—hematologic cancer	6.74e-06	3.58e-05	CcSEcCtD
Zonisamide—Headache—Methotrexate—hematologic cancer	6.7e-06	3.56e-05	CcSEcCtD
Zonisamide—Asthenia—Doxorubicin—hematologic cancer	6.65e-06	3.53e-05	CcSEcCtD
Zonisamide—Dizziness—Epirubicin—hematologic cancer	6.62e-06	3.52e-05	CcSEcCtD
Zonisamide—Pruritus—Doxorubicin—hematologic cancer	6.55e-06	3.48e-05	CcSEcCtD
Zonisamide—Vomiting—Epirubicin—hematologic cancer	6.37e-06	3.38e-05	CcSEcCtD
Zonisamide—Nausea—Methotrexate—hematologic cancer	6.35e-06	3.37e-05	CcSEcCtD
Zonisamide—Diarrhoea—Doxorubicin—hematologic cancer	6.34e-06	3.37e-05	CcSEcCtD
Zonisamide—Rash—Epirubicin—hematologic cancer	6.31e-06	3.35e-05	CcSEcCtD
Zonisamide—Dermatitis—Epirubicin—hematologic cancer	6.31e-06	3.35e-05	CcSEcCtD
Zonisamide—Headache—Epirubicin—hematologic cancer	6.27e-06	3.33e-05	CcSEcCtD
Zonisamide—Dizziness—Doxorubicin—hematologic cancer	6.13e-06	3.25e-05	CcSEcCtD
Zonisamide—Nausea—Epirubicin—hematologic cancer	5.95e-06	3.16e-05	CcSEcCtD
Zonisamide—Vomiting—Doxorubicin—hematologic cancer	5.89e-06	3.13e-05	CcSEcCtD
Zonisamide—Rash—Doxorubicin—hematologic cancer	5.84e-06	3.1e-05	CcSEcCtD
Zonisamide—Dermatitis—Doxorubicin—hematologic cancer	5.84e-06	3.1e-05	CcSEcCtD
Zonisamide—Headache—Doxorubicin—hematologic cancer	5.8e-06	3.08e-05	CcSEcCtD
Zonisamide—Nausea—Doxorubicin—hematologic cancer	5.5e-06	2.92e-05	CcSEcCtD
Zonisamide—CYP2C19—Metabolism—SLC35B2—hematologic cancer	3.43e-06	3.28e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—MAP2K1—hematologic cancer	3.41e-06	3.26e-05	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—MAPK3—hematologic cancer	3.4e-06	3.26e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—PIK3CD—hematologic cancer	3.39e-06	3.24e-05	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—AKT1—hematologic cancer	3.38e-06	3.24e-05	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—AKT1—hematologic cancer	3.38e-06	3.24e-05	CbGpPWpGaD
Zonisamide—CA14—Metabolism—EP300—hematologic cancer	3.36e-06	3.22e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—CREBBP—hematologic cancer	3.32e-06	3.18e-05	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—TGFB1—hematologic cancer	3.3e-06	3.16e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PIK3CG—hematologic cancer	3.29e-06	3.15e-05	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—EP300—hematologic cancer	3.28e-06	3.14e-05	CbGpPWpGaD
Zonisamide—CA6—Metabolism—EP300—hematologic cancer	3.28e-06	3.14e-05	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—AKT1—hematologic cancer	3.26e-06	3.12e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—MTHFR—hematologic cancer	3.25e-06	3.11e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—FGF2—hematologic cancer	3.24e-06	3.1e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PIK3CG—hematologic cancer	3.23e-06	3.09e-05	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PTEN—hematologic cancer	3.21e-06	3.07e-05	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PTEN—hematologic cancer	3.21e-06	3.07e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—PIK3R1—hematologic cancer	3.2e-06	3.06e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PHYH—hematologic cancer	3.2e-06	3.06e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GMPS—hematologic cancer	3.2e-06	3.06e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—FTCD—hematologic cancer	3.2e-06	3.06e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—CREBBP—hematologic cancer	3.18e-06	3.05e-05	CbGpPWpGaD
Zonisamide—CA3—Metabolism—AKT1—hematologic cancer	3.15e-06	3.02e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PIK3CD—hematologic cancer	3.15e-06	3.01e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—MTAP—hematologic cancer	3.13e-06	3e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—JAK2—hematologic cancer	3.11e-06	2.98e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—ALB—hematologic cancer	3.11e-06	2.97e-05	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—TNF—hematologic cancer	3.08e-06	2.95e-05	CbGpPWpGaD
Zonisamide—CA7—Metabolism—EP300—hematologic cancer	3.06e-06	2.93e-05	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—EP300—hematologic cancer	3.06e-06	2.93e-05	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—KRAS—hematologic cancer	3.06e-06	2.93e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—CREBBP—hematologic cancer	3.05e-06	2.92e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—MDM2—hematologic cancer	3.03e-06	2.9e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PIK3CD—hematologic cancer	3.02e-06	2.89e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CD44—hematologic cancer	3.01e-06	2.88e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—NQO1—hematologic cancer	3.01e-06	2.88e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—CREBBP—hematologic cancer	2.99e-06	2.86e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—ALB—hematologic cancer	2.98e-06	2.85e-05	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PTEN—hematologic cancer	2.97e-06	2.84e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PIK3R1—hematologic cancer	2.97e-06	2.84e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—MTOR—hematologic cancer	2.95e-06	2.83e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—PIK3CB—hematologic cancer	2.95e-06	2.83e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—CD4—hematologic cancer	2.95e-06	2.82e-05	CbGpPWpGaD
Zonisamide—MAOA—Neuronal System—HRAS—hematologic cancer	2.94e-06	2.81e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SMPD3—hematologic cancer	2.92e-06	2.8e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PIK3CG—hematologic cancer	2.89e-06	2.77e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PIK3CD—hematologic cancer	2.89e-06	2.77e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—ALB—hematologic cancer	2.86e-06	2.73e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PIK3R1—hematologic cancer	2.85e-06	2.73e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CYCS—hematologic cancer	2.84e-06	2.72e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PIK3CD—hematologic cancer	2.84e-06	2.72e-05	CbGpPWpGaD
Zonisamide—CA12—Metabolism—EP300—hematologic cancer	2.83e-06	2.71e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—HSP90AA1—hematologic cancer	2.83e-06	2.71e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—ALB—hematologic cancer	2.8e-06	2.68e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—FHL2—hematologic cancer	2.79e-06	2.67e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—CDKN1B—hematologic cancer	2.77e-06	2.65e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PIK3CB—hematologic cancer	2.74e-06	2.63e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—AGRN—hematologic cancer	2.74e-06	2.62e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PIK3R1—hematologic cancer	2.73e-06	2.61e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PIK3CG—hematologic cancer	2.73e-06	2.61e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—CREBBP—hematologic cancer	2.68e-06	2.57e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PIK3R1—hematologic cancer	2.68e-06	2.56e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PIK3CB—hematologic cancer	2.63e-06	2.52e-05	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—HRAS—hematologic cancer	2.6e-06	2.49e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—IDH2—hematologic cancer	2.6e-06	2.49e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—HMMR—hematologic cancer	2.6e-06	2.49e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—CDKN1A—hematologic cancer	2.56e-06	2.45e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ASNS—hematologic cancer	2.56e-06	2.45e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—DCK—hematologic cancer	2.56e-06	2.45e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—B3GAT1—hematologic cancer	2.56e-06	2.45e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—PTEN—hematologic cancer	2.55e-06	2.44e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PIK3CD—hematologic cancer	2.54e-06	2.43e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—CREBBP—hematologic cancer	2.53e-06	2.42e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PIK3CB—hematologic cancer	2.52e-06	2.41e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—ALB—hematologic cancer	2.51e-06	2.4e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GSTP1—hematologic cancer	2.51e-06	2.4e-05	CbGpPWpGaD
Zonisamide—CA14—Metabolism—PIK3CA—hematologic cancer	2.49e-06	2.38e-05	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—IL6—hematologic cancer	2.49e-06	2.38e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PIK3CB—hematologic cancer	2.47e-06	2.37e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	2.45e-06	2.34e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ARNTL—hematologic cancer	2.44e-06	2.34e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—EP300—hematologic cancer	2.43e-06	2.33e-05	CbGpPWpGaD
Zonisamide—CA6—Metabolism—PIK3CA—hematologic cancer	2.42e-06	2.32e-05	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—PIK3CA—hematologic cancer	2.42e-06	2.32e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—HDC—hematologic cancer	2.42e-06	2.32e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PIK3R1—hematologic cancer	2.4e-06	2.3e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PIK3CD—hematologic cancer	2.4e-06	2.29e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CA9—hematologic cancer	2.38e-06	2.27e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ACP5—hematologic cancer	2.38e-06	2.27e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—ABCB1—hematologic cancer	2.37e-06	2.27e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PTEN—hematologic cancer	2.37e-06	2.27e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—ALB—hematologic cancer	2.37e-06	2.26e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—SRC—hematologic cancer	2.37e-06	2.26e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NCOR2—hematologic cancer	2.34e-06	2.24e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—NCOR1—hematologic cancer	2.3e-06	2.21e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GSTM1—hematologic cancer	2.3e-06	2.21e-05	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—AKT1—hematologic cancer	2.29e-06	2.2e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—STAT3—hematologic cancer	2.28e-06	2.18e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—NRAS—hematologic cancer	2.28e-06	2.18e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PTEN—hematologic cancer	2.27e-06	2.18e-05	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PIK3CA—hematologic cancer	2.26e-06	2.17e-05	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PIK3CA—hematologic cancer	2.26e-06	2.17e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PIK3R1—hematologic cancer	2.26e-06	2.17e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—EP300—hematologic cancer	2.26e-06	2.16e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—IDH1—hematologic cancer	2.23e-06	2.14e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CDA—hematologic cancer	2.22e-06	2.12e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PIK3CB—hematologic cancer	2.22e-06	2.12e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ABCC3—hematologic cancer	2.21e-06	2.11e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—TXN—hematologic cancer	2.21e-06	2.11e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSTO1—hematologic cancer	2.21e-06	2.11e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—MAPK3—hematologic cancer	2.18e-06	2.09e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PTEN—hematologic cancer	2.18e-06	2.09e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—EP300—hematologic cancer	2.17e-06	2.07e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SPHK1—hematologic cancer	2.16e-06	2.07e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PTEN—hematologic cancer	2.14e-06	2.04e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PC—hematologic cancer	2.13e-06	2.04e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—MYC—hematologic cancer	2.12e-06	2.03e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—TGFB1—hematologic cancer	2.11e-06	2.02e-05	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PIK3CA—hematologic cancer	2.1e-06	2.01e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PIK3CB—hematologic cancer	2.09e-06	2e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—EP300—hematologic cancer	2.08e-06	1.99e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—UGT1A1—hematologic cancer	2.08e-06	1.99e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GBA—hematologic cancer	2.06e-06	1.97e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SLC35B2—hematologic cancer	2.06e-06	1.97e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—EP300—hematologic cancer	2.04e-06	1.95e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—MTHFR—hematologic cancer	2.04e-06	1.95e-05	CbGpPWpGaD
Zonisamide—CA14—Metabolism—AKT1—hematologic cancer	2.03e-06	1.95e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SLC22A1—hematologic cancer	2.02e-06	1.93e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CRABP1—hematologic cancer	2.02e-06	1.93e-05	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—AKT1—hematologic cancer	1.98e-06	1.9e-05	CbGpPWpGaD
Zonisamide—CA6—Metabolism—AKT1—hematologic cancer	1.98e-06	1.9e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ALOX5—hematologic cancer	1.97e-06	1.88e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—KRAS—hematologic cancer	1.96e-06	1.87e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PTEN—hematologic cancer	1.92e-06	1.83e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NUP98—hematologic cancer	1.91e-06	1.82e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—MTAP—hematologic cancer	1.88e-06	1.8e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ADCY7—hematologic cancer	1.85e-06	1.77e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NCOA3—hematologic cancer	1.85e-06	1.77e-05	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—AKT1—hematologic cancer	1.85e-06	1.77e-05	CbGpPWpGaD
Zonisamide—CA7—Metabolism—AKT1—hematologic cancer	1.85e-06	1.77e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NUP214—hematologic cancer	1.84e-06	1.76e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—EP300—hematologic cancer	1.83e-06	1.75e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.82e-06	1.74e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PTEN—hematologic cancer	1.81e-06	1.73e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ABCG2—hematologic cancer	1.8e-06	1.72e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—MTR—hematologic cancer	1.8e-06	1.72e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—PIK3CA—hematologic cancer	1.8e-06	1.72e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ENO2—hematologic cancer	1.77e-06	1.69e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—EP300—hematologic cancer	1.72e-06	1.65e-05	CbGpPWpGaD
Zonisamide—CA12—Metabolism—AKT1—hematologic cancer	1.71e-06	1.64e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSTT1—hematologic cancer	1.71e-06	1.64e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PIK3CG—hematologic cancer	1.71e-06	1.64e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.69e-06	1.61e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—FHL2—hematologic cancer	1.68e-06	1.61e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SDC1—hematologic cancer	1.67e-06	1.6e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PIK3CA—hematologic cancer	1.67e-06	1.6e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—HRAS—hematologic cancer	1.67e-06	1.59e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—AGRN—hematologic cancer	1.65e-06	1.58e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PIK3CA—hematologic cancer	1.6e-06	1.53e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.6e-06	1.53e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—IL6—hematologic cancer	1.59e-06	1.53e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CREBBP—hematologic cancer	1.59e-06	1.52e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.58e-06	1.51e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—IDH2—hematologic cancer	1.56e-06	1.49e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—HMMR—hematologic cancer	1.56e-06	1.49e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PIK3CA—hematologic cancer	1.54e-06	1.47e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.51e-06	1.44e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PIK3CA—hematologic cancer	1.51e-06	1.44e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PIK3CD—hematologic cancer	1.5e-06	1.44e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—ALB—hematologic cancer	1.48e-06	1.42e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—AKT1—hematologic cancer	1.47e-06	1.41e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ARNTL—hematologic cancer	1.47e-06	1.41e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ACP5—hematologic cancer	1.43e-06	1.37e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CA9—hematologic cancer	1.43e-06	1.37e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NQO1—hematologic cancer	1.42e-06	1.36e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CD44—hematologic cancer	1.42e-06	1.36e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PIK3R1—hematologic cancer	1.42e-06	1.36e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NCOR2—hematologic cancer	1.41e-06	1.35e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.39e-06	1.33e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—AKT1—hematologic cancer	1.37e-06	1.31e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PIK3CA—hematologic cancer	1.35e-06	1.29e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYCS—hematologic cancer	1.35e-06	1.29e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—IDH1—hematologic cancer	1.34e-06	1.29e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	1.34e-06	1.28e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTO1—hematologic cancer	1.33e-06	1.27e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ABCC3—hematologic cancer	1.33e-06	1.27e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—TXN—hematologic cancer	1.33e-06	1.27e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PIK3CB—hematologic cancer	1.31e-06	1.25e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—AKT1—hematologic cancer	1.31e-06	1.25e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SPHK1—hematologic cancer	1.3e-06	1.24e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PIK3CA—hematologic cancer	1.27e-06	1.22e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—AKT1—hematologic cancer	1.26e-06	1.2e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—UGT1A1—hematologic cancer	1.25e-06	1.19e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—AKT1—hematologic cancer	1.23e-06	1.18e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SLC22A1—hematologic cancer	1.21e-06	1.16e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CRABP1—hematologic cancer	1.21e-06	1.16e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.2e-06	1.15e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSTP1—hematologic cancer	1.19e-06	1.14e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ALOX5—hematologic cancer	1.18e-06	1.13e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.15e-06	1.1e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NUP98—hematologic cancer	1.15e-06	1.1e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PTEN—hematologic cancer	1.13e-06	1.08e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ABCB1—hematologic cancer	1.12e-06	1.08e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NCOA3—hematologic cancer	1.11e-06	1.07e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ADCY7—hematologic cancer	1.11e-06	1.07e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NUP214—hematologic cancer	1.1e-06	1.06e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—AKT1—hematologic cancer	1.1e-06	1.06e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSTM1—hematologic cancer	1.09e-06	1.04e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NCOR1—hematologic cancer	1.09e-06	1.04e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ABCG2—hematologic cancer	1.08e-06	1.04e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—MTR—hematologic cancer	1.08e-06	1.04e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—EP300—hematologic cancer	1.08e-06	1.03e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ENO2—hematologic cancer	1.06e-06	1.02e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—AKT1—hematologic cancer	1.04e-06	9.96e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTT1—hematologic cancer	1.03e-06	9.85e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SDC1—hematologic cancer	1.01e-06	9.63e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—MTHFR—hematologic cancer	9.64e-07	9.23e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CD44—hematologic cancer	8.56e-07	8.19e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NQO1—hematologic cancer	8.56e-07	8.19e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	8.49e-07	8.13e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PIK3CG—hematologic cancer	8.1e-07	7.75e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYCS—hematologic cancer	8.1e-07	7.75e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	8.04e-07	7.7e-06	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PIK3CA—hematologic cancer	7.99e-07	7.65e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CREBBP—hematologic cancer	7.51e-07	7.19e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTP1—hematologic cancer	7.14e-07	6.83e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PIK3CD—hematologic cancer	7.12e-07	6.81e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ALB—hematologic cancer	7.03e-07	6.73e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ABCB1—hematologic cancer	6.76e-07	6.47e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PIK3R1—hematologic cancer	6.72e-07	6.43e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NCOR1—hematologic cancer	6.56e-07	6.28e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTM1—hematologic cancer	6.56e-07	6.28e-06	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—AKT1—hematologic cancer	6.53e-07	6.25e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PIK3CB—hematologic cancer	6.21e-07	5.94e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—MTHFR—hematologic cancer	5.8e-07	5.55e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PTEN—hematologic cancer	5.36e-07	5.13e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—EP300—hematologic cancer	5.11e-07	4.89e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PIK3CG—hematologic cancer	4.87e-07	4.66e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CREBBP—hematologic cancer	4.51e-07	4.32e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PIK3CD—hematologic cancer	4.28e-07	4.1e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ALB—hematologic cancer	4.23e-07	4.04e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PIK3R1—hematologic cancer	4.04e-07	3.87e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PIK3CA—hematologic cancer	3.78e-07	3.62e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PIK3CB—hematologic cancer	3.73e-07	3.57e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PTEN—hematologic cancer	3.22e-07	3.09e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—AKT1—hematologic cancer	3.09e-07	2.96e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—EP300—hematologic cancer	3.07e-07	2.94e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PIK3CA—hematologic cancer	2.27e-07	2.18e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—AKT1—hematologic cancer	1.86e-07	1.78e-06	CbGpPWpGaD
